Mucosal Immunity
34.4K views | +19 today
Mucosal Immunity
The largest immune tissue in the body
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
August 26, 2020 7:56 AM
Scoop.it!

New discovery: Antibody that may protect against Covid-19 infection identified

-...
No comment yet.
Rescooped by Gilbert C FAURE from Virus World
August 25, 2020 8:37 AM
Scoop.it!

COVID-19 Can Spread In Surprising Ways We Didn’t Realize

COVID-19 Can Spread In Surprising Ways We Didn’t Realize | Mucosal Immunity | Scoop.it

The results of 3 new studies reveal unknown ways until now that COVID-19 spreads, leading scientists to urge the use of face coverings in public. Research from various parts of the world considered three separate factors in each study: low humidity, public restrooms and airborne dust. The implications from all three of these studies? Mask up!

 

Low Humidity

A study just published in Transboundary and Emerging Diseases confirms an earlier study conducted in the Greater Sydney, Australia area during the early stages of the pandemic that reported a link between low humidity and community spread of COVID-19. The new research led by Dr. Michael Ward in the Sydney School of Veterinary Science adds to the growing body of evidence that low humidity is a key factor in the spread of the Coronavirus. The scientists estimated that for a 1% decrease in relative humidity, COVID-19 cases increase by 7 to 8%. The same link was not found in other weather patterns such as rainfall, temperature or wind. According to Ward, dry air favors the spread of the virus: “”When the humidity is lower, the air is drier and it makes the aerosols smaller,” he said, adding that aerosols are smaller than droplets. “When you sneeze and cough those smaller infectious aerosols can stay suspended in the air for longer. That increases the exposure for other people. When the air is humid and the aerosols are larger and heavier, they fall and hit surfaces quicker.” These findings add to a growing body of research that recommends wearing a mask.

 

Public Restrooms

A second study conducted by Chinese researchers from Yangzhou University reported that flushing a public restroom toilet or urinal can release clouds of virus-laden aerosols that can be inhaled, posing a serious public health challenge. The scientists simulated and tracked virus-laden particle movements when toilets and urinals were flushed. They discovered that flushing involves an interaction between gas and liquid, resulting in a large spread of aerosol particles. The disturbing results revealed that the trajectory of the particles ejected from flushing showed that more than 57% of the particles traveled away from the urinal. The researchers further point out that when men use urinals in a public restroom, these tiny particles can reach their thigh within 5.5 seconds when compared to the toilet flush, which takes 35 seconds to reach slightly higher. “From our work, it can be inferred that urnial flushing indeed promotes the spread of bacteria and viruses,” said Xiang-Dong Liu, one of the study’s authors. “Wearing a mask should be mandatory within public restrooms during the pandemic, and anti-diffusion improvements are urgently needed to prevent the spread of COVID-19.”

 

Airborne Dust

A third study from the University of California, Davis and the Icahn School of Medicine at Mt. Sinai reported that influenza viruses can spread through the air on dust, fibers and other microscopic particles. Until now, scientists assumed airborne transmission occurred mainly due to respiratory droplets by coughing, sneezing or talking. The scientists examined whether tiny, non-respiratory particles could carry influenza between guinea pigs. Using an automated particle sizer to count airborne particles, they found that uninfected guinea pigs give off spikes of up to 1,000 particles per second as they move around the cage. Particles given off by the animals’ breathing were at a constant but lower rate. Immune guinea pigs with influenza virus painted on their fur could transmit the virus through the air to other, susceptible guinea pigs, showing that the virus did not have to come directly from the respiratory tract to be infectious. Next the researchers tested whether microscopic fibers from an inanimate object could carry infectious viruses. They treated paper facial tissues with influenza virus, let them dry out and then crumpled them in front of the automated particle sizer. Crumpling the tissues released up to 900 particles per second in a size range that could be inhaled. They were also able to infect cells from these particles released from the virus-contaminated paper tissues. According to the researchers, the surprising findings that dust can spread viruses have obvious implications for Coronavirus transmission and use of masks for protection. Plus, they said, it opens up an entire new field of investigation on how outbreaks are interpreted.

 

Original studies available in these sites:

https://doi.org/10.1063/5.0021450

https://doi.org/10.1038/s41467-020-17888-w

https://doi.org/10.1111/tbed.13766


Via Juan Lama
No comment yet.
Scooped by Gilbert C FAURE
August 19, 2020 3:00 PM
Scoop.it!

Acquisition of a multifunctional IgA + plasma cell phenotype in the gut

Acquisition of a multifunctional IgA + plasma cell phenotype in the gut | Mucosal Immunity | Scoop.it
IgA secreting plasma cells in the lamina propria are shown to be an important source of iNOS and TNF required to maintain the homeostatic balance between intestinal microbes and the immune system. The gut contains a vast number of bacteria that are essential for the health of the organism, but it is also a rich source of lymphocytes that exist to eliminate infections. How do lymphocytes restrain themselves from attacking beneficial bacteria, yet maintain their ability to respond to true pathogens? Fritz et al. show that as B cells differentiate into plasma cells in the gut, they adopt a phenotype reminiscent of innate immune cells — inflammatory monocytes — while maintaining their ability to produce immunoglobulin. The resulting immunoglobulin-A-secreting plasma cells in the lamina propria are shown to be the main source of the antimicrobial mediators tumour necrosis factor-α and inducible nitric oxide synthase, which are required to maintain the homeostatic balance between intestinal microbes and the immune system. The largest mucosal surface in the body is in the gastrointestinal tract, a location that is heavily colonized by microbes that are normally harmless. A key mechanism required for maintaining a homeostatic balance between this microbial burden and the lymphocytes that densely populate the gastrointestinal tract is the production and transepithelial transport of poly-reactive IgA (ref. 1). Within the mucosal tissues, B cells respond to cytokines, sometimes in the absence of T-cell help, undergo class switch recombination of their immunoglobulin receptor to IgA, and differentiate to become plasma cells2. However, IgA-secreting plasma cells probably have additional attributes that are needed for coping with the tremendous bacterial load in the gastrointestinal tract. Here we report that mouse IgA+ plasma cells also produce the antimicrobial mediators tumour-necrosis factor-α (TNF-α) and inducible nitric oxide synthase (iNOS), and express many molecules that are commonly associated with monocyte/granulocytic cell types. The development of iNOS-producing IgA+ plasma cells can be recapitulated in vitro in the presence of gut stroma, and the acquisition of this multifunctional phenotype in vivo and in vitro relies on microbial co-stimulation. Deletion of TNF-α and iNOS in B-lineage cells resulted in a reduction in IgA production, altered diversification of the gut microbiota and poor clearance of a gut-tropic pathogen. These findings reveal a novel adaptation to maintaining homeostasis in the gut, and extend the repertoire of protective responses exhibited by some B-lineage cells.
No comment yet.
Scooped by Gilbert C FAURE
July 27, 2020 3:09 AM
Scoop.it!

olfactory epithelium and Covid-19 by sciencemaghttps://advances.sciencemag.org/content/early/2020/07/24/sciadv.abc5801.1?

olfactory epithelium and Covid-19 by sciencemag

Gilbert C FAURE's insight:

Abstract:

Altered olfactory function is a common symptom of COVID-19, but its etiology is unknown. A key question is whether SARS-CoV-2 (CoV-2) – the causal agent in COVID-19 – affects olfaction directly, by infecting olfactory sensory neurons or their targets in the olfactory bulb, or indirectly, through perturbation of supporting cells. Here we identify cell types in the olfactory epithelium and olfactory bulb that express SARS-CoV-2 cell entry molecules. Bulk sequencing demonstrated that mouse, non-human primate and human olfactory mucosa expresses two key genes involved in CoV-2 entry, ACE2 and TMPRSS2. However, single cell sequencing revealed that ACE2 is expressed in support cells, stem cells, and perivascular cells, rather than in neurons. Immunostaining confirmed these results and revealed pervasive expression of ACE2 protein in dorsally-located olfactory epithelial sustentacular cells and olfactory bulb pericytes in the mouse. These findings suggest that CoV-2 infection of non-neuronal cell types leads to anosmia and related disturbances in odor perception in COVID-19 patients.

No comment yet.
Scooped by Gilbert C FAURE
July 23, 2020 6:56 AM
Scoop.it!

COVID-19 : Un traitement « révolutionnaire » pour réduire les infections graves

COVID-19 : Un traitement « révolutionnaire » pour réduire les infections graves | Mucosal Immunity | Scoop.it
L’entreprise britannique Synairgen déclare avoir conçu un traitement permettant de réduire largement les risques de mortalité en cas de contamination par le SARS-CoV-2. La formule, baptisée SNG001, affiche des résultats significatifs ; ceux-ci n’ont toutefois pas encore été validés par un comité...
No comment yet.
Scooped by Gilbert C FAURE
June 25, 2020 2:54 AM
Scoop.it!

On sait désormais pourquoi le coronavirus fait parfois perdre l’odorat

On sait désormais pourquoi le coronavirus fait parfois perdre l’odorat | Mucosal Immunity | Scoop.it
L’infection par le SARS-CoV-2 s’accompagne parfois d’une perte d’odorat. La bonne nouvelle ? Celui-ci devrait très probablement être de retour une fois l’infection terminée. Plus ou moins vite.
No comment yet.
Scooped by Gilbert C FAURE
June 1, 2020 1:41 AM
Scoop.it!

https://medicalxpress.com/news/2020-05-scientists-isolate-covid-virus-feces.html

virus in feces and on surfaces

No comment yet.
Scooped by Gilbert C FAURE
May 21, 2020 4:26 AM
Scoop.it!

COVID-19 Cytokine storm: Possible mechanism for the deadly respiratory syndrome –

COVID-19 Cytokine storm: Possible mechanism for the deadly respiratory syndrome – | Mucosal Immunity | Scoop.it
Credit: Toshio Hirano and Masaaki Murakami. Immunity.April 22, 2020 Research into how the SARS-CoV-2 virus induces death is suggesting...
No comment yet.
Scooped by Gilbert C FAURE
May 8, 2020 11:44 AM
Scoop.it!

https://www.thelancet.com/action/showPdf?pii=S2665-9913%2820%2930121-1

Lung and coagulopathy and macrophages

No comment yet.
Scooped by Gilbert C FAURE
May 5, 2020 2:31 AM
Scoop.it!

CD45 T cell and macrophage infiltration characteristic of COVID-19 related lung injury

CD45 T cell and macrophage infiltration characteristic of COVID-19 related lung injury | Mucosal Immunity | Scoop.it
1. In this case series, imaging mass cytometry revealed aberrant CD45RA+ T cells in the lung tissue of patients with COVID-19. 2. The identities of infiltrated cells were determined to be CD4 and CD8
No comment yet.
Scooped by Gilbert C FAURE
May 4, 2020 4:38 AM
Scoop.it!

COVID‐19: searching for clues among other respiratory viruses - Nguyen‐Robertson - 2020 - Immunology & Cell Biology

COVID‐19: searching for clues among other respiratory viruses - Nguyen‐Robertson - 2020 - Immunology & Cell Biology | Mucosal Immunity | Scoop.it
See Trending Virtual Issue...
No comment yet.
Scooped by Gilbert C FAURE
May 1, 2020 1:46 PM
Scoop.it!

SARS-CoV-2 productively infects human gut enterocytes | Science

No comment yet.
Scooped by Gilbert C FAURE
April 23, 2020 2:46 AM
Scoop.it!

Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs | medRxiv

medRxiv - The Preprint Server for Health Sciences
Gilbert C FAURE's insight:

virological detection in a neglected fluid

No comment yet.
Scooped by Gilbert C FAURE
August 26, 2020 7:54 AM
Scoop.it!

A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2 - ScienceDirect

The Coronavirus Disease 2019 pandemic has made deployment of an effective vaccine a global health priority.We evaluated the protective activity of a …...
No comment yet.
Scooped by Gilbert C FAURE
August 20, 2020 9:15 AM
Scoop.it!

The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing | medRxiv

medRxiv - The Preprint Server for Health Sciences
Gilbert C FAURE's insight:

Abstract

Understanding the mechanism that leads to immune dysfunction induced by SARS-CoV2 virus is crucial to develop treatment for severe COVID-19. Here, using single cell RNA-seq, we characterized the peripheral blood mononuclear cells (PBMC) from uninfected controls and COVID-19 patients, and cells in paired broncho-alveolar lavage fluid (BALF). We found a close association of decreased dendritic cells (DC) and increased monocytes resembling myeloid-derived suppressor cells (MDSC) which correlated with lymphopenia and inflammation in the blood of severe COVID-19 patients. Those MDSC-like monocytes were immune-paralyzed. In contrast, monocyte-macrophages in BALFs of COVID-19 patients produced massive amounts of cytokines and chemokines, but secreted little interferons. The frequencies of peripheral T cells and NK cells were significantly decreased in severe COVID-19 patients, especially for innate-like T and various CD8+ T cell subsets, compared to health controls. In contrast, the proportions of various activated CD4+ T cell subsets, including Th1, Th2 and Th17-like cells were increased and more clonally expanded in severe COVID-19 patients. Patients' peripheral T cells showed no sign of exhaustion or augmented cell death, whereas T cells in BALFs produced higher levels of IFNG, TNF, CCL4 and CCL5 etc. Paired TCR tracking indicated abundant recruitment of peripheral T cells to the patients' lung. Together, this study comprehensively depicts how the immune cell landscape is perturbed in severe COVID-19.

No comment yet.
Scooped by Gilbert C FAURE
August 11, 2020 9:39 AM
Scoop.it!

Gargling with mouthwashes might lower spread of COVID-19, say scientists

Gargling with mouthwashes might lower spread of COVID-19, say scientists | Mucosal Immunity | Scoop.it
According to the researchers, including those from Ruhr University Bochum in Germany, high quantities of the virus particles, or viral load, can be detected in the oral cavity and throat of some COVID-19 patients.
Gilbert C FAURE's insight:

back from the past, already in use in 1918

No comment yet.
Rescooped by Gilbert C FAURE from Virus World
July 25, 2020 2:54 PM
Scoop.it!

Sputum Testing Provides Higher Rate of COVID-19 Detection

Sputum Testing Provides Higher Rate of COVID-19 Detection | Mucosal Immunity | Scoop.it

Early and accurate detection is critical for preventing the spread of COVID-19 and providing appropriate care for patients. Nasopharyngeal (NP) swabs, which require inserting a long shaft into the nasal cavity to collect a sample from the back of the nose and throat, are currently the gold standard for collecting a specimen for diagnosis. But the procedure is technically challenging, often uncomfortable for patients and requires personal protective equipment that may be in short supply. Other approaches to collecting specimens—including from an oropharyngeal swab and sputum—have been tested in small studies, but there is uncertainty about which method is best for detecting the virus. In a new study published in EBioMedicine, investigators from Brigham and Women's Hospital conducted a systematic review and meta-analysis, analyzing data from more than 3,000 specimens to compare the three approaches. The team found that sputum testing detected the RNA of the virus that causes COVID-19 at significantly higher rates while oropharyngeal swab testing had lower rates. Regardless of the collection method, the earlier samples were collected after symptoms began, the higher the detection rate.

 

"The accurate diagnosis of COVID-19 has implications for health care, return-to-work, infection control and public health," said corresponding author Jonathan Li, MD, a faculty member in the Division of Infectious Diseases at the Brigham. "Our gold standard in and out of the hospital is the nasopharyngeal swab, but there's a lot of confusion about which sampling modality is best and most sensitive. Our study shows that sputum testing resulted in significantly higher rates of SARS-CoV-2 detection and supports the use of this type of testing as a valuable method for the diagnosis and monitoring of COVID-19 patients." Li and his colleagues scoured the literature—both preprints and published papers—for studies that assessed at least two respiratory sampling sites using an NP swab, oropharyngeal swab or sputum. From more than 1,000 studies, they identified 11 that met their criteria. These studies included results from a total of 3,442 respiratory tract specimens. The team examined how often each collection method produced a positive result. For NP swabs, the rate was 54 percent; for oropharyngeal swabs, 43 percent; for sputum, 71 percent. The rate of viral detection was significantly higher in sputum than either oropharyngeal swabs or NP swabs. Detection rates were highest within one week of symptom onset for all three tests.

 

Study Published in EbioMedicine (July 18, 2020):

https://doi.org/10.1016/j.ebiom.2020.102903


Via Juan Lama
No comment yet.
Scooped by Gilbert C FAURE
July 10, 2020 11:02 AM
Scoop.it!

Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic? - ScienceDirect

Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic? - ScienceDirect | Mucosal Immunity | Scoop.it
Coronavirus disease 2019 (COVID-19) first emerged in late 2019 in China.At the time of writing, its causative agent SARS-CoV-2 has spread worldwide i…...
No comment yet.
Scooped by Gilbert C FAURE
June 5, 2020 9:36 AM
Scoop.it!

Reverse genetics allows researchers to map SARS-CoV-2 in the body

Reverse genetics allows researchers to map SARS-CoV-2 in the body | Mucosal Immunity | Scoop.it
A new study has revealed that SARS-CoV-2 infects the nasal cavity to the greatest degree and infects and replicates progressively less well in cells lower in the respiratory tract. The work, including the development of key laboratory tools, has been accepted by Cell.
No comment yet.
Scooped by Gilbert C FAURE
May 25, 2020 6:49 AM
Scoop.it!

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 | NEJM

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 | NEJM | Mucosal Immunity | Scoop.it
Abstract Background Progressive respiratory failure is the primary cause of death in the coronavirus disease 2019 (Covid-19) pandemic. Despite widespread interest in the pathophysiology of th
No comment yet.
Scooped by Gilbert C FAURE
May 17, 2020 11:40 AM
Scoop.it!

The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission | PNAS

The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission | PNAS | Mucosal Immunity | Scoop.it
No comment yet.
Scooped by Gilbert C FAURE
May 5, 2020 2:56 AM
Scoop.it!

Bad News – Coronavirus SARS-CoV-2 Infects Cells of the Intestine and Multiplies There

Bad News – Coronavirus SARS-CoV-2 Infects Cells of the Intestine and Multiplies There | Mucosal Immunity | Scoop.it
Researchers from the Hubrecht Institute in Utrecht, Erasmus MC University Medical Center Rotterdam, and Maastricht University in the Netherlands have found that the coronavirus SARS-CoV-2, which causes COVID-19, can infect cells of the intestine and multiply there. Using state-of-the-art cell cultur
No comment yet.
Scooped by Gilbert C FAURE
May 5, 2020 2:19 AM
Scoop.it!

https://www.sciencedirect.com/science/article/pii/S0016508520302821?fbclid=IwAR09NprFxmRrGP_SHw8kBz8qC1sa1X_7nvL_4FmPa2_9Q_6rgJ7NfMHTldY Covid in GI tract

No comment yet.
Scooped by Gilbert C FAURE
May 2, 2020 9:21 AM
Scoop.it!

SARS-CoV-2 transmission exploits existing secretory pathways in the nasal cavity: a vaccine/drug target?  | Immunopaedia

Investigators in a brief communication in Nature Medicine utilised the Covid19 cell atlas database to identify gene expression of the SARS-CoV-2 entry receptor ACE2 and other genes potentially associated with pathogenesis using known single-cell RNA sequencing datasets.
No comment yet.
Scooped by Gilbert C FAURE
April 28, 2020 1:48 PM
Scoop.it!

Is SARS-CoV-2 Also an Enteric Pathogen with Potential Fecal-Oral Transmission: A COVID-19 Virological and Clinical Review

Is SARS-CoV-2 Also an Enteric Pathogen with Potential Fecal-Oral Transmission: A COVID-19 Virological and Clinical Review

No comment yet.